Request medical information
Prescribing information
Contact us
What is ROZLYTREK?
Introduction to ROZLYTREK
MoA and CNS activity
ROS1
+ NSCLC
Study design
Patient characteristics
Efficacy
CNS efficacy
NTRK
fusion+ solid tumours
Study design
Patient characteristics
Efficacy
CNS efficacy
ROZLYTREK safety overview
ROZLYTREK safety summary
ROZLYTREK adverse reactions
Monitoring
Prescribing ROZLYTREK
ROZLYTREK dosing
Download the ROZLYTREK SmPC
Patient benefits
Lung cancer patient
Breast cancer patient
Sarcoma patient
Gene fusion detection
Introduction to clinically actionable fusions
NTRK
ROS1
Testing guidelines
Disease support
Coming soon
Request medical information
Prescribing information
Contact us
Error 404
Sorry, we cannot find the page you are looking for.
We suggest to visit our homepage
OK
Submit
Return